Immediate Impact
1 from Science/Nature 57 standout
Citing Papers
Bacteriophage therapy for multidrug-resistant infections: current technologies and therapeutic approaches
2025 Standout
The immunology of type 1 diabetes
2024 Standout
Works of Christopher M. Bearden being referenced
Rituximab Inhibits the In Vivo Primary and Secondary Antibody Response to a Neoantigen, Bacteriophage phiX174
2005
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Christopher M. Bearden | 255 | 172 | 164 | 9 | 493 | |
| E. Felber | 295 | 168 | 270 | 12 | 531 | |
| H. Bashir | 79 | 71 | 201 | 9 | 499 | |
| A. McLean | 314 | 136 | 86 | 16 | 503 | |
| Clare Nasmyth‐Miller | 278 | 124 | 76 | 11 | 484 | |
| George Wadih | 289 | 272 | 118 | 11 | 537 | |
| J M Rendall | 230 | 166 | 86 | 8 | 447 | |
| Marion E. Paape | 112 | 94 | 333 | 9 | 548 | |
| Anne Fuller | 228 | 119 | 266 | 13 | 442 | |
| Eleonora G. Galvanek | 129 | 142 | 78 | 16 | 473 | |
| Constanze Schoenemann | 223 | 188 | 164 | 17 | 443 |
All Works
Loading papers...